Background and Objective: Pseudomonas aeruginosa (P. aeruginosa) cause serious nosocomial and non-nosocomial infections. The bla and bla OXA24/40 induce resistance to carbapenems. The current study aimed at detecting blaOXA-23 and blaOXA-24/40 in P. aeruginosa strains isolated from patients with nosocomial and non-nosocomial infections.
Introduction
Pseudomonas aeruginosa (P. aeruginosa) is the most common bacterial pathogen found in serious nosocomial and also non-nosocomial infections. Some of the infections caused by these bacteria are pneumonia, urinary tract infection (UTI), surgical strains are the common extended-spectrum beta-lactamase (ESBL) producers among pathogenic bacteria (3) . According to Ambler Classification, beta-lactamases are classified into four groups of A, B, C, and D. Different genes encode class D beta-lactamases; in addition, they are poorly inhibited by clavulanic and ethylenediaminetetraacetic acids (EDTA), and have many differences in the amino acid sequences (4) . The following types are examples of this enzyme: OXA (Oxacilinase)-1, 2, 10, 13, and 17 that are the prototype gene and cause resistance to oxacillin and cephalosporin (2) . On the other hand, carbapenemhydrolyzing class D beta-lactamases such as OXA-23 and -24/40 induce resistance to carbapenems such as imipenem (IMP), meropenem (MEM), and doripenem (DRP). Hydrophobic bridge formed by Tyr112 and Met223 plays an important role in carbapenemase activity of this enzyme (5) . OXA-23 was firstly reported in 1995 and OXA-24/40 was identified in Spain in 2000 (6, 7) . Epidemiology of carbapenemresistant P. aeruginosa (CRPA) is studied in different geographical parts of the world and ranges from 10% to 50%. The lowest rates of CRPA are reported in Canada (3.3%) and the Dominican Republic (8%), and higher rates are observed in Brazil, Peru, Costa Rica, Russia, Greece, Poland, Iran, and Saudi Ara¬bia (above 50%). The geographical distribution of CRPA is gradually increasing (8) . Molecular and phenotypic techniques such as polymerase chain reaction (PCR) and disk diffusion method are used to study antibiotic resistant P. aeruginosa (9) (10) (11) . According to the above mentioned contents, treatment of infections caused by P. aeruginosa harboring bla and bla OXA24/40 is very difficult. No study is conducted so far on the distribution of these genes in P. aeruginosa in Kurdistan Province, Iran. According to the increasing resistance, and failure of antibiotics to remove P. aeruginosa, the current study was conducted to investigate P. aeruginosa strains harboring bla and bla OXA24/40 and evaluate their characteristics. Such information can be used in healthcare centers and the hospital infection control practices advisory committees in order to make better decisions regarding the control and prevention of infectious diseases caused by these bacteria, which in turn can help to properly prescribe antibiotics. Therefore, the current study aimed at investigating the phenotypic and molecular detections of bla and bla OXA24/40 among P. aeruginosa strains isolated from patients with nosocomial and non-nosocomial infections in different tertiary hospitals in Kurdistan Province, Iran.
Materials and methods
The current descriptive cross sectional study was conducted at the Cellular and Molecular Research Center of Kurdistan University of Medical Sciences, Sanandaj, Iran from December 2015 to August 2017. All Pseudomonas spp. isolated from 49 females and 97 males admitted to tertiary hospitals were collected ( Table 2 ). Inclusion criteria of the current study were admission to tertiary hospitals; having infections caused by P. aeruginosa, and isolation of P. aeruginosa from their clinical specimens. Strains that were not identified in molecular and phenotypic tests as P. aeruginosa and those that did not grow on bacterial cultures were excluded from the study. The study protocol was also approved by the Ethics Committee of the local university (ethical code: MUK.REC. 1394/337). Overall, 146 strains of Pseudomonas spp. were isolated. Patients' demographic information was collected from the hospital information system (HIS). Nosocomial and non-nosocomial P. aeruginosa infections were also detected according to the definition of centers for disease control and prevention (CDC) (12) . For P. aeruginosa species, phonotypic features were detected using microbiological methods (13) . To extract DNA for PCR, single and pure colonies of overnight culture on Mueller-Hinton agar (MHA) (Merck, Germany) were dissolved in 500 µL of sterile deionized water in a 1.5-mL tube; then, powdered glass was added to them slightly; 500 µL of Tris-EDTA (ethylenediaminetetraacetic acid) (10 mM Tris, 1 mM EDTA, pH 8.0) was also added to them. After centrifugation (7000 rpm, five minutes), 3 µL of supernatant was used for PCR as DNA template. For P. aeruginosa molecular detection by PCR, gyrB (gyrase B) forward (F) and reverse (R) primers (SinaClon, Iran) in a final volume of 25 µL (7.5 µL deionized water, 3 µL DNA template, 1µL each F and R primers, and 12.5 µL Master mix) were used. P. aeruginosa ATCC 25922 (Darvash, Iran) and deionized water were applied as positive and negative controls, respectively (Table 1) (14) . For antibiotic sensitivity testing, a suspension of P. aeruginosa adjusted to 0.5 McFarland turbidity standard was prepared, and then, was cultured on MHA. Kirby-Bauer disk diffusion method was applied according to Clinical and Laboratory Standards Institute (CLSI) guidelines with IMP (10 µg) (Rosco, Denmark) (12) . Multiplex PCR for bla and bla OXA-24/40 using F-and R-primers (SinaClon, Iran) were performed. Acinetobacter baumannii strains harboring bla and bla and distilled water were respectively used as positive and negative controls in this assay (Table 1) (15) . The PCR was amplified with the final volume of 21 µL (8 µL deionized water, 2 µL DNA template, 0.2 µL of each F and R primers for bla and bla , and 10 µL Master mix) (7) . Stata software version 12 using Fisher exact test and logistic regression analysis were used to analyze the data (P ≤0.05). 
Discussion
P. aeruginosa cause infection in different hospital wards (2, 16 ). In the current study, among 146 Pseudomonas spp., 91.09% using phenotypic test and 91.78% using gyrB-PCR were identified as P. aeruginosa. Based on the results of phenotypic test and gyrB-PCR for P. aeruginosa, Farajzadeh Sheikh et al., reported all the 223 isolates as P. aeruginosa (17) . PCR is a rapid technique; it is a gold standard with high sensitivity and specificity, and it is reliable to identify microbial pathogens (17, 18 ). In the current study, most P. aeruginosa strains were isolated from Toohid Hospital (70.89%), followed by Besat Hospital (24.62%). Since Toohid and Besat hospitals are the tertiary referral centers in Sanandaj, the center of Kurdistan Province, Iran, and most of the patients are referred to them from surrounding cities, the highest rates of infection were reported from these hospitals. Nosocomial infection caused by P. aeruginosa was observed in 41.79% of inpatients. The majority of P. aeruginosa strains were isolated from intensive care units (ICUs) (29.85%) of which 69.64% were related to nosocomial infections. Verma et al., in India reported 24% and 18% prevalence of P. aeruginosa respectively from burn ward and ICU in patients with nosocomial infection. In addition, resistance to antibiotics in these wards were high (19) . Due to the fact that P. aeruginosa is an MDR and opportunistic pathogen; it can cause nosocomial infection, especially among inpatients admitted to ICU. Moreover, personal underlying risk factors such as nature and duration of invasive procedures used, length of ICU and hospital stay, and antibiotic treatment can affect the different rates of nosocomial infections in ICUs (19, 20) . Results of the antibiotic sensitivity testing against IMP showed that bacteria isolated from nosocomial infections were more resistant to IMP (22.22%). Mohsenpour et al., reported that 134 isolates out of 374 were IMP-resistant, while 240 were IMP-sensitive; the resistance rates were higher in ICU and patients with nosocomial infections, which was similar to the results of the current study (21) . Major factors leading to carbapenem-resistance are metallo-beta-lactamases (class D MBLs) and carbapenem-hydrolyzing oxacillinases (15) . However, rates of antibiotic resistance in a study tend to differ according to certain factors such as type of antibiotics, genetic variations of bacteria and resistant strains, and differences in antibiotic consumption pattern at different locations (22) .In the current study, bla and bla were detected in 11.19% and 2.23% of the isolates, respectively. In addition, bla was detected in 7.14% of the patients with nosocomial infections. By performing multiplex PCR, Esenkaya Taşbent and Özdemir showed that of 184 IMP-and/or MEM-resistant Pseudomonas spp. strains isolated from different clinical samples, 6.5% and 0.54% were positive for bla and bla , respectively (23) . In the current study, 0.45% of 15 IMP-resistant isolates were the bla OXA-23 carriers, but none of the resistant isolates were bla carriers. To justify this matter, the environment and/or genetic context can modify the phenotypic expression of resistant genes and thus, genotype does not always result in the expected phenotype (24) . The results were similar to those of the current study. Based on the results of PCR, Odumosu et al., showed that the prevalence of bla in P. aeruginosa strains was 80% (10) . Multiplex PCR results in a study by Farsiani et al., showed harboring bla in all 36 isolates of A. baumannii and accordingly, the prevalence of bla was 64% (15) . These rates in the study by Odumosu were higher than those of the current study about bla OXA genes. According to the results of PCR, Aghazadeh et al., detected OXA I, II, and III in P. aeruginosa species, and enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR) proved high genetic diversity among these isolates (2) . In a study by Saderi et al., 39.06% of 94 P. aeruginosa isolates were MBLs producers. They used the combination disk diffusion method to detect MBL-producing P. aeruginosa (25) . Different mechanisms of gene transfer such as horizontal gene transfer (including transposable elements) can be the cause of transmission of class D carbapenem-hydrolyzing beta-lactamases genes among different bacterial strains; it is a global con¬cern threatening all the countries and communities (9, 15, 26, 27) . Finally, the following can be considered as the strength points of the current study: clinical samples were gathered in the span of three years, employment of CLSI guidelines to diagnose and determine resistance patterns of bacteria, the employment of PCR method, and using easy-to-access and cost-effective methods. However, weaknesses and limitations of the current study were possible contamination of the laboratory environment, which may lead to false results and lack of access to the medical history and specimens of all the patients.
Conclusion
In the current study, IMP-resistant P. aeruginosa strains were detected in different clinical samples taken from patients with nosocomial and non-nosocomial infections. Some of the isolates carried OXA genes. Carbapenems are still the most important and effective antibiotics against different infections caused by P. aeruginosa; therefore, according to the current study results, more effective planning and measures should be taken in order to determine the resistance and prevalence of such genes in the studied strains, and control and prevent the spread of these bacteria in hospital wards.
